BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 8097805)

  • 1. Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
    Zambon A; Torres A; Bijvoet S; Gagne C; Moorjani S; Lupien PJ; Hayden MR; Brunzell JD
    Lancet; 1993 May; 341(8853):1119-21. PubMed ID: 8097805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.
    Thompson GR
    Atherosclerosis; 2018 Sep; 276():148-154. PubMed ID: 30064057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
    Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
    Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia.
    Raal FJ; Areias AJ; Waisberg R; von Arb M
    Atherosclerosis; 1995 May; 115(1):9-15. PubMed ID: 7669091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
    Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T
    Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia.
    Moorjani S; Roy M; Torres A; Bétard C; Gagné C; Lambert M; Brun D; Davignon J; Lupien P
    Lancet; 1993 May; 341(8856):1303-6. PubMed ID: 8098448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia.
    Raal FJ; Pilcher GJ; Waisberg R; Buthelezi EP; Veller MG; Joffe BI
    Am J Cardiol; 1999 May; 83(9):1330-3. PubMed ID: 10235090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.
    Pimstone SN; Gagné SE; Gagné C; Lupien PJ; Gaudet D; Williams RR; Kotze M; Reymer PW; Defesche JC; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1704-12. PubMed ID: 7583547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.
    Vega GL; Hobbs HH; Grundy SM
    Arterioscler Thromb; 1991; 11(3):578-85. PubMed ID: 2029498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia.
    Deiana L; Garuti R; Pes GM; Carru C; Errigo A; Rolleri M; Pisciotta L; Masturzo P; Cantafora A; Calandra S; Bertolini S
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):236-43. PubMed ID: 10634824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia.
    Paiker JE; Raal FJ; von Arb M
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():174-8. PubMed ID: 10735360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
    Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
    Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance.
    Yanagi K; Yamashita S; Kihara S; Nakamura T; Nozaki S; Nagai Y; Funahashi T; Kameda-Takemura K; Ueyama Y; Jiao S; Kubo M; Tokunaga K; Matsuzawa Y
    Atherosclerosis; 1997 Jul; 132(1):43-51. PubMed ID: 9247358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.